Status | Study |
Recruiting |
Study Name: Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC) Condition: Fibrolamellar Hepatocellular Carcinoma Hepatocellular Carcinoma Date: 2016-02-26 Interventions: Procedure: living related donor partial liver transplantation |
Recruiting |
Study Name: A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma Condition: Advanced Adult Hepatocellular Carcinoma Advanced Fibrolamellar Carcino Date: 2014-09-05 Interventions: Drug: ENMD-2076 250 mg oral dose, QD for 28 day cycles |
Active, not recruiting |
Study Name: Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) Condition: Fibrolamellar Carcinoma Fibrolamellar Liver Cancer Date: 2012-07-12 Interventions: Drug: everolimus Drug: letrozole plus leup |
Terminated |
Study Name: Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma Condition: Hepatocellular Carcinoma Fibrolamellar Hepatocellular Carcinoma Date: 2010-09-24 Interventions: Drug: Sutent Sunitinib 50mg/day (per os) for 6 cycles duration of one cycle = 6 weeks (4 weeks of treatm |